Qiyu Biotech
company
About
Qiyu Biotech is an innovative macromolecular drug developer.
- 11 - 50
Details
- Last Funding Type
- Series A
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jul 1, 2017
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Qi Xiangdong, founder of Qiyu Bio, said: “Innovation is the starting and future of Qiyu Bio, and it is the core driving force of enterprise development. Qiyu Bio will use the first-class antibody technology platform to build superior biopharmaceutical pipelines and explore the field of biotherapy. A big breakthrough. With the development and improvement of the company, Qiyu will have core competitiveness in more fields.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥200M
Qiyu Biotech has raised a total of
¥200M
in funding over 2 rounds. Their latest funding was raised on
Dec 23, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 23, 2021 | Series B | ¥200M | 2 | — | — | Detail |
| Aug 13, 2019 | Series A | — | 2 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
4
Qiyu Biotech is funded by 4 investors.
Watson Investment
and Jundu Investment
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series A |
|
|
Yes | Series A |
|
|
— | Series B |
Longmen Capital
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
